Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism
2008 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Growth differentiation factor-15 for prognostic assessment of patients with acute pulmonary embolism
Lankeit, M. K.; Kennpf, T.; Dellas, C.; Cuny, M.; Tapken, H.; Peter, T. & Olschewski, M. et al. (2008)
American Journal of Respiratory and Critical Care Medicine, 177(9) pp. 1018-1025. DOI: https://doi.org/10.1164/rccm.200712-1786OC
Documents & Media
Details
- Authors
- Lankeit, Mareike K.; Kennpf, Tibor; Dellas, Claudia; Cuny, Mayumi; Tapken, Heike; Peter, Timo; Olschewski, Manfred; Konstantinides, Stavros V.; Wollert, Kai C.
- Abstract
- Rationale: Growth differentiation factor (GDF)-15 is a cytokine induced in the heart after ischemia or pressure overload. Circulating levels of GDF-15 provide independent prognostic information in patients with acute coronary syndromes or heart failure. Objectives: We investigated the prognostic value of GDF-15 in acute pulmonary embolism. Methods: In a prospective cohort study, plasma levels of GDF-15 were determined by immunoradiometric assay in 123 consecutive patients with confirmed acute pulmonary embolism. Measurements and Main Results: GDF-15 concentrations on admission ranged from 553 to 47,274 ng/L; 101 patients (82%) had GDF-15 levels above the upper limit of normal (1,200 ng/L). Patients who experienced pulmonary embolism-related complications during the first 30 days had higher baseline levels of GDF-15 (median, 6,039 [25th to 75th percentiles, 2,778 to 19,772] ng/L) compared with those with an uncomplicated course (median, 2036 [25th to 75th percentiles, 1,279 to 3,176] ng/L; P< 0.001). By multivariable logistic regression analysis, which included clinical characteristics, cardiac biomarkers (troponin T and NT-proBNP [N-terminal propeptide of B-type natriuretic peptide]), and echocardiographic findings, GDF-15 emerged as an independent predictor of a complicated 30-day outcome (P = 0.033). The c-statistic for GDF-15 was 0.84 (95% confidence interval, 0.76-0.90), as compared with 0.72 for cardiac troponin T, and 0.65 for NT-proBNP. The ability of troponin T, NT-proBNP, and echocardiographic findings of right ventricular dysfunction to predict the risk of a complicated 30-day outcome was enhanced by GDF-15. Furthermore, multivariable Cox regression identified baseline levels of GDF-15 as an independent predictor of long-term mortality (P < 0.001). Conclusions: GDF-15 is a promising new biomarker for risk stratification of pulmonary embolism.
- Issue Date
- 2008
- Status
- published
- Publisher
- Amer Thoracic Soc
- Journal
- American Journal of Respiratory and Critical Care Medicine
- ISSN
- 1073-449X